Synergy Pharmaceuticals files $250 million stock and preferreds shelf

By Devika Patel

Knoxville, Tenn., June 21 - Synergy Pharmaceuticals, Inc. filed a $250 million shelf registration in an S-3 filing with the Securities and Exchange Commission.

The registration covers common stock, preferred stock, units and warrants.

The preferreds may be structured as convertibles.

The New York private pharmaceutical company will use the proceeds for general corporate purposes.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.